Noevir Announces Consolidated Results for the First Six Months of the Fiscal Year Ending September 30, 2026

May 13, 2026

Trade name: Noevir Holdings Co., Ltd.

Listing: Tokyo Stock Exchange, Prime Market (Securities Code: 4928) URL: https://www.noevirholdings.co.jp/

Representative: Takashi Okura, President and CEO Contact: Junya Baba, General Manager, Accounting

Tel. +81-78-303-5121

Submission of semi-annual securities report: May 15, 2026 Date of commencement of dividend payments: -Supplemental materials for the financial results prepared: Yes

Results briefing for the reporting period held: Yes (for institutional investors and analysts)

(Amounts under one million yen have been rounded down)

1. Operating results for the first six months of the fiscal year ending September 30, 2026 (October 1, 2025 to March 31, 2026)

   1. Consolidated operating results

      (Millions of yen; percentage figures denote year-on-year change)

      	Net sales		Operating income		Ordinary income		Net income attributable to owners of the parent
      Six months ended March 31, 2026	30,615	(4.4)%	4,534	(20.6)%	4,789	(20.5)%	2,718	2.9%
      Six months ended March 31, 2025	32,037	1.3%	5,712	(7.3)%	6,025	(3.5)%	2,641	1.7%

      Note: Comprehensive income:

      Six months ended March 31, 2026: 3,135 million yen [18.9%]

      Six months ended March 31, 2025: 2,637 million yen [(14.9)%]

      	EPS (Yen)	Diluted EPS (Yen)
      Six months ended March 31, 2026	79.59	-
      Six months ended March 31, 2025	77.34	-

   2. Consolidated financial position

   (Millions of yen)

   	Total assets	Net assets	Equity ratio (%)
   As of March 31, 2026	71,736	49,489	68.1
   As of September 30, 2025	76,492	54,209	70.3

   [Reference] Equity:

   As of March 31, 2026: 48,862 million yen

   As of September 30, 2025: 53,767 million yen

2. Cash dividends

   (Yen)

   	Annual dividends
   	1st quarter	2nd quarter	3rd quarter	Year-end	Total
   Fiscal year ended September 30, 2025	-	0.00	-	230.00	230.00
   Fiscal year ended September 30, 2026	-	0.00
   Fiscal year ending September 30, 2026 (forecast)			-	230.00	230.00

   Note: Revisions from the most recently announced dividend forecast: None

3. Consolidated earnings forecasts for the fiscal year ending September 30, 2026 (October 1, 2025 to September 30, 2026)

(Millions of yen; percentage figures denote year-on-year change)

Note: Revisions from the most recently announced consolidated earnings forecast: None

* Notes

1. Significant changes in the scope of consolidation during the period: None

2. Special accounting treatment for preparation of semi-annual consolidated financial statements: None

3. Changes in accounting policies, changes in accounting estimates, and restatement

   1. Changes associated with revision in accounting standards: None

   2. Other changes: None

   3. Changes in accounting estimates: None

   4. Restatement: None

4. Shares outstanding (common stock)

   1. Shares outstanding (including treasury stock) As of March 31, 2026: 34,156,623

      As of September 30, 2025: 34,156,623

   2. Treasury shares outstanding As of March 31, 2026: 416

      As of September 30, 2025: 416

   3. Average shares outstanding over quarter

Six months ended March 31, 2026: 34,156,207

Six months ended March 31, 2025: 34,156,207

• Semi-annual financial results reports are exempt from review conducted by certified public accountants or an audit firm.

• Explanation regarding the appropriate use of business performance forecasts

  Forward-looking statements included in these materials, such as forecasts of business performance, are based on information known to the Company's management as of the time of writing, and reflect judgments believed to be reasonable on the basis of that information. There is, therefore, a possibility that actual business performance figures will differ substantially from our forecasts as a result of changes in the economic situation and other unforeseeable factors. Please refer to "(3) Estimates and forecasts pertaining to future plans and business results" under "1. Operating results and financial information" on page 5 of the Attached Material.

  Contents of the Attached Material

  1. Operating results and financial information 4

     1. Operating results for the first six months of the fiscal year ending September 30, 2026 4

     2. Financial position as of March 31, 2026 5

     3. Estimates and forecasts pertaining to future plans and business results 5

  2. Semi-annual consolidated financial statements and notes 6

1. Semi-annual consolidated balance sheets 6

2. Semi-annual consolidated statements of income and comprehensive income 8

3. Semi-annual consolidated statements of cash flows 10

4. Notes to the semi-annual consolidated financial statements 11

(Note on assumptions for going concern) 11

(Note on significant changes in the amount of shareholders' equity) 11

(Note on segment information) 11

1. ‌Operating results and financial information‌

   1. Operating results for the first six months of the fiscal year ending September 30, 2026 Consolidated operating results for the first six months of the fiscal year ending September 30, 2026 (October 1, 2025 to March 31, 2026)

      	Six months ended March 31, 2025		Six months ended March 31, 2026		Change (Millions of yen)	Change (%)
      	Net sales (Millions of yen)	% of Total	Net sales (Millions of yen)	% of Total
      Net sales	32,037	100.0	30,615	100.0	(1,421)	(4.4)
      Cosmetics	25,442	79.4	24,173	79.0	(1,269)	(5.0)
      Pharmaceuticals & Health Food	5,596	17.5	5,385	17.6	(211)	(3.8)
      Other	998	3.1	1,057	3.4	59	6.0

      	Six months ended March 31, 2025		Six months ended March 31, 2026		Change (Millions of yen)	Change (%)
      	Amount (Millions of yen)	% of Net sales	Amount (Millions of yen)	% of Net sales
      Operating income	5,712	17.8	4,534	14.8	(1,177)	(20.6)
      Ordinary income	6,025	18.8	4,789	15.6	(1,235)	(20.5)
      Net income attributable to owners of the parent	2,671	8.2	2,718	8.9	76	2.9

      During the first six months of fiscal 2026 (October 1, 2025 to March 31, 2026), economic trends remained uncertain due to factors such as the impact of conditions in the Middle East, although some signs of a moderate recovery were observed.

      In this environment, the Company is working to realize the concept of its medium- to long-term strategy: "Realizing steady corporate growth by securing sustainability in every Group business segment."

      As a result, net sales for the first six months of fiscal 2026 came to 30,615 million yen (down 4.4% year on year), operating income was 4,534 million yen (down 20.6%), ordinary income was 4,789 million yen (down 20.5%), and net income attributable to owners of the parent came to 2,718 million yen (up 2.9%).

      In the Cosmetics segment, net sales totaled 24,173 million yen (down 5.0% year on year), and segment income came to 5,357 million yen (down 16.5%).

      In the Pharmaceuticals & Health Food segment, net sales totaled 5,385 million yen (down 3.8% year on year), and segment income came to 389 million yen (down 8.5%).

      In the Other segment, net sales totaled 1,057 million yen (up 6.0% year on year), and segment income came to 59 million yen (down 41.6%).

   2. ‌Financial position as of March 31, 2026

      Total assets as of March 31, 2026 stood at 71,736 million yen, a decrease of 4,756 million yen from the previous fiscal year-end. This was mainly due to decreases in cash and deposits of 3,506 million yen and notes and accounts receivable of 1,417 million yen.

      Total liabilities came to 22,246 million yen, a decrease of 36 million yen from the previous fiscal year-end. This mainly reflected decreases in other accounts payable of 320 million yen and guarantee deposits received of 200 million yen, while there was an increase in income tax payable of 359 million yen.

      Net assets came to 49,489 million yen, a decrease of 4,719 million yen from the previous fiscal year-end.

      This was primarily attributable to a decrease in retained earnings of 5,137 million yen, due to the payment of 7,855 million yen in dividends at the previous fiscal year-end, which was partly offset by Net income attributable to owners of the parent of 2,718 million yen.

      As a result, the equity ratio stood at 68.1%. (Consolidated cash flows)

      Cash and cash equivalents (hereinafter, "cash") on a consolidated basis as of the end of the period under review stood at 23,215 million yen, a decrease of 3,507 million yen compared with the previous fiscal year-end.

      The status of each cash flow together with the factors contributing to their increase or decrease for the first six months of fiscal 2026 are presented as follows.

      (Cash flows from operating activities)

      Net cash provided by operating activities amounted to 3,080 million yen (compared with an inflow of 3,986 million yen in the corresponding period of the previous fiscal year). The main item increasing cash was 5,426 million yen in income before income taxes, while the main item decreasing cash was 2,107 million yen in net income tax paid.

      (Cash flows from investing activities)

      Net cash provided by investing activities came to 1,063 million yen (compared with an outflow of 1,769 million yen in the corresponding period of the previous fiscal year). The principal cash inflow was 1,415 million yen for proceeds from sale of property, plant and equipment.

      (Cash flows from financing activities)

      Net cash used in financing activities came to 7,895 million yen (compared with an outflow of 7,722 million yen in the corresponding period of the previous fiscal year). This was mainly due to the payment of 7,852 million yen in dividends.

   3. ‌Estimates and forecasts pertaining to future plans and business results

The consolidated business performance forecasts for the full year ending September 30, 2026, announced on November 7, 2025, remain unchanged.